Evidence map›Paper›PMID 26590088›Full record

ArticleMolecular and cellular biochemistry2016

Ascorbic acid prevents VEGF-induced increases in endothelial barrier permeability.

Esad Ulker, William H Parker, Amita Raj, Zhi-chao Qu, James M May

Abstract read
In one paragraph

Article in Molecular and cellular biochemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 38 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Vitamin C and Cardiovascular Disease: An Update.Antioxidants (Basel, Switzerland) · 2020
    Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Effects of uric acid on vascular endothelial function from bedside to bench.Hypertension research : official journal of the Japanese Society of Hypertension · 2018
    Article
  20. Ascorbic acid attenuates endothelial permeability triggered by cell-free hemoglobin.Biochemical and biophysical research communications · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Esad UlkerDepartment of Medicine, Vanderbilt University School of Medicine, 7465 Medical Research Building IV, Nashville, TN, 37232-0475, USA.
William H ParkerDepartment of Medicine, Vanderbilt University School of Medicine, 7465 Medical Research Building IV, Nashville, TN, 37232-0475, USA.
Amita RajDepartment of Medicine, Vanderbilt University School of Medicine, 7465 Medical Research Building IV, Nashville, TN, 37232-0475, USA.
Zhi-chao QuDepartment of Medicine, Vanderbilt University School of Medicine, 7465 Medical Research Building IV, Nashville, TN, 37232-0475, USA.
James M MayDepartment of Medicine, Vanderbilt University School of Medicine, 7465 Medical Research Building IV, Nashville, TN, 37232-0475, USA. james.may@vanderbilt.edu.
Vanderbilt University · US

Funding

Vanderbilt Diabetes Research CenterP30DK020593 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI OWEN P MCGUINNESS · 2012 to 2026
$29.3M
TRANSGENIC MOUSE/ ES CELL SHARES RESOURCESP60DK020593 · NIDDK · VANDERBILT UNIVERSITY · PI MCGUINNESS, OWEN P · 1986 to 2011
$28.1M
ASCORBIC ACID FUNCTION AND METABOLISMR01DK050435 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MAY, JAMES M. · 1995 to 2015
$4.0M
NIDDK NIH HHS DK020593NIDDK NIH HHS DK050435NIDDK NIH HHS P30 DK020593NIDDK NIH HHS P60 DK020593NIDDK NIH HHS R01 DK050435
6 · The paper itself

Abstract

Vascular endothelial growth factor (VEGF) increases endothelial barrier permeability, an effect that may contribute to macular edema in diabetic retinopathy. Since vitamin C, or ascorbic acid, can tighten the endothelial permeability barrier, we examined whether it could prevent the increase in permeability due to VEGF in human umbilical vein endothelial cells (HUVECs). As previously observed, VEGF increased HUVEC permeability to radiolabeled inulin within 60 min in a concentration-dependent manner. Loading the cells with increasing concentrations of ascorbate progressively prevented the leakage caused by 100 ng/ml VEGF, with a significant inhibition at 13 µM and complete inhibition at 50 µM. Loading cells with 100 µM ascorbate also decreased the basal generation of reactive oxygen species and prevented the increase caused by both 100 ng/ml VEGF. VEGF treatment decreased intracellular ascorbate by 25%, thus linking ascorbate oxidation to its prevention of VEGF-induced barrier leakage. The latter was blocked by treating the cells with 60 µM L-NAME (but not D-NAME) as well as by 30 µM sepiapterin, a precursor of tetrahydrobiopterin that is required for proper function of endothelial nitric oxide synthase (eNOS). These findings suggest that VEGF-induced barrier leakage uncouples eNOS. Ascorbate inhibition of the VEGF effect could thus be due either to scavenging superoxide or to peroxynitrite generated by the uncoupled eNOS, or more likely to its ability to recycle tetrahydrobiopterin, thus avoiding enzyme uncoupling in the first place. Ascorbate prevention of VEGF-induced increases in endothelial permeability opens the possibility that its repletion could benefit diabetic macular edema.

Indexed as

AntioxidantsAscorbic AcidEndothelium, VascularHumansHuman Umbilical Vein Endothelial CellsNitric OxidePermeabilityVascular Endothelial Growth Factor AAntioxidantsAscorbic AcidNitric OxideVascular Endothelial Growth Factor AAscorbic acidEndothelial cellsEndothelial nitric oxide synthaseOxidative stressVEGF

Identifiers

PMID26590088
PMCPMC4718828
OpenAlexW2287485136

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.